Adicet Bio, Inc. Financing Cash Flow
Adicet Bio, Inc. (ACET) reported Financing Cash Flow of -$7.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-05
- Adicet Bio, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $58.00K, a 78.28% decline year-over-year.
- Adicet Bio, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was -$65.00K.
- Adicet Bio, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $75.23M, a 54813.87% increase year-over-year.
- Adicet Bio, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was -$150.00K.
- Adicet Bio, Inc. net cash provided by (used in) financing activities for fiscal 2025 was $75.25M, a 32.40% decline from fiscal 2024.
- Adicet Bio, Inc. net cash provided by (used in) financing activities for fiscal 2024 was $111.31M, a 47063.98% increase from fiscal 2023.
- Adicet Bio, Inc. net cash provided by (used in) financing activities for fiscal 2023 was $236.00K, a 99.43% decline from fiscal 2022.
- Adicet Bio, Inc. net cash provided by (used in) financing activities for fiscal 2022 was $41.51M, a 82.90% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 3 month as first filed | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 6 month as first filed | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 9 month as first filed | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $58.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$7.00K 10-Q · filed 2026-08-05 | $75.22M derived: sum of 3 quarters · filed 2026-08-05 | $75.08M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2026-03-31 | -$65.00K 10-Q · filed 2026-05-13 | $75.17M derived: sum of 2 quarters · filed 2026-05-13 | $75.02M derived: sum of 3 quarters · filed 2026-05-13 | $75.28M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-12-31 | $75.23M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $75.08M derived: sum of 2 quarters · filed 2026-03-12 | $75.35M derived: sum of 3 quarters · filed 2026-08-05 | $75.25M 10-K · filed 2026-03-12 | ||||
| 2025-09-30 | -$150.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $117.00K derived: sum of 2 quarters · filed 2026-08-05 | $13.00K 10-Q · filed 2025-11-05 | $150.00K derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-06-30 | $267.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $163.00K 10-Q · filed 2026-08-05 | $300.00K derived: sum of 3 quarters · filed 2026-08-05 | $300.00K derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-03-31 | -$104.00K 10-Q · filed 2026-05-13 | $33.00K derived: sum of 2 quarters · filed 2026-05-13 | $33.00K derived: sum of 3 quarters · filed 2026-05-13 | $237.00K derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | $137.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $137.00K derived: sum of 2 quarters · filed 2026-03-12 | $341.00K derived: sum of 3 quarters · filed 2026-03-12 | $111.31M 10-K · filed 2026-03-12 | ||||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $204.00K derived: sum of 2 quarters · filed 2025-11-05 | $111.17M 10-Q · filed 2025-11-05 | $111.25M derived: sum of 4 quarters · filed 2025-11-05 | ||||
| 2024-06-30 | $204.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $111.17M 10-Q · filed 2025-08-07 | $111.25M derived: sum of 3 quarters · filed 2025-08-07 | $111.19M derived: sum of 4 quarters · filed 2025-08-07 | ||||
| 2024-03-31 | $110.97M 10-Q · filed 2025-05-06 | $111.04M derived: sum of 2 quarters · filed 2025-05-06 | $110.98M derived: sum of 3 quarters · filed 2025-05-06 | $111.21M derived: sum of 4 quarters · filed 2025-05-06 | ||||
| 2023-12-31 | $76.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $17.00K derived: sum of 2 quarters · filed 2025-03-06 | $243.00K derived: sum of 3 quarters · filed 2025-03-06 | $236.00K 10-K · filed 2025-03-06 | ||||
| 2023-09-30 | -$59.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $167.00K derived: sum of 2 quarters · filed 2024-11-06 | $160.00K 10-Q · filed 2024-11-06 | $464.00K derived: sum of 4 quarters · filed 2024-11-06 | ||||
| 2023-06-30 | $226.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $219.00K 10-Q · filed 2024-08-13 | $523.00K derived: sum of 3 quarters · filed 2024-08-13 | $42.70M derived: sum of 4 quarters · filed 2024-08-13 | ||||
| 2023-03-31 | -$7.00K 10-Q · filed 2024-05-14 | $297.00K derived: sum of 2 quarters · filed 2024-05-14 | $42.47M derived: sum of 3 quarters · filed 2024-05-14 | $42.64M derived: sum of 4 quarters · filed 2024-05-14 | ||||
| 2022-12-31 | $304.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | $42.48M derived: sum of 2 quarters · filed 2024-03-19 | $42.64M derived: sum of 3 quarters · filed 2024-03-19 | $41.51M 10-K · filed 2024-03-19 | ||||
| 2022-09-30 | $42.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $42.34M derived: sum of 2 quarters · filed 2023-11-08 | $41.20M 10-Q · filed 2023-11-08 | $138.67M derived: sum of 4 quarters · filed 2023-11-08 | ||||
| 2022-06-30 | $163.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$971.00K 10-Q · filed 2023-08-09 | $96.49M derived: sum of 3 quarters · filed 2023-08-09 | $96.85M derived: sum of 4 quarters · filed 2023-08-09 | ||||
| 2022-03-31 | -$1.13M 10-Q · filed 2023-05-09 | $96.33M derived: sum of 2 quarters · filed 2023-05-09 | $96.69M derived: sum of 3 quarters · filed 2023-05-09 | $96.66M derived: sum of 4 quarters · filed 2023-05-09 | ||||
| 2021-12-31 | $97.46M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $97.83M derived: sum of 2 quarters · filed 2023-03-15 | $97.80M derived: sum of 3 quarters · filed 2023-03-15 | $242.69M 10-K · filed 2023-03-15 | ||||
| 2021-09-30 | $362.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $335.00K derived: sum of 2 quarters · filed 2022-11-08 | $145.22M 10-Q · filed 2022-11-08 | $145.49M derived: sum of 4 quarters · filed 2022-11-08 | ||||
| 2021-06-30 | -$27.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $144.86M 10-Q · filed 2022-08-10 | $145.13M derived: sum of 3 quarters · filed 2022-08-10 | $145.27M derived: sum of 4 quarters · filed 2022-08-10 | ||||
| 2021-03-31 | $144.89M 10-Q · filed 2022-05-12 | $145.15M derived: sum of 2 quarters · filed 2022-05-12 | $145.30M derived: sum of 3 quarters · filed 2022-05-12 | $145.15M derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | $267.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $411.00K derived: sum of 2 quarters · filed 2022-03-15 | $261.00K derived: sum of 3 quarters · filed 2022-03-15 | $303.00K 10-K · filed 2022-03-15 | ||||
| 2020-09-30 | $144.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$6.00K derived: sum of 2 quarters · filed 2021-11-10 | $36.00K 10-Q · filed 2021-11-10 | -$87.00K derived: sum of 4 quarters · filed 2021-11-10 | ||||
| 2020-06-30 | -$150.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$108.00K 10-Q · filed 2021-08-12 | -$2.00K 10-Q · filed 2020-07-30 | -$231.00K derived: sum of 3 quarters · filed 2021-08-12 | $26.47M derived: sum of 4 quarters · filed 2021-08-12 | |||
| 2020-03-31 | $42.00K 10-Q · filed 2021-05-17 | -$1.00K 10-Q · filed 2020-05-07 | -$81.00K derived: sum of 2 quarters · filed 2021-05-17 | $26.62M derived: sum of 3 quarters · filed 2021-05-17 | $30.17M derived: sum of 4 quarters · filed 2021-05-17 | |||
| 2019-12-31 | -$123.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $26.58M derived: sum of 2 quarters · filed 2021-03-12 | $30.13M derived: sum of 3 quarters · filed 2021-03-12 | $76.94M 10-K · filed 2021-03-12 | $56.45M 10-K · filed 2020-03-12 | |||
| 2019-09-30 | $26.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $30.25M derived: sum of 2 quarters · filed 2020-11-05 | $77.07M 10-Q · filed 2020-11-05 | $56.46M 10-Q · filed 2019-11-05 | -$1.82M derived: sum of 4 quarters · filed 2021-03-12 | |||
| 2019-06-30 | $3.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | $50.37M 10-Q · filed 2020-07-30 | -$28.53M derived: sum of 3 quarters · filed 2021-03-12 | -$28.53M derived: sum of 4 quarters · filed 2021-03-12 | ||||
| 2019-03-31 | $46.82M 10-Q · filed 2020-05-07 | -$32.08M derived: sum of 2 quarters · filed 2021-03-12 | -$32.08M derived: sum of 3 quarters · filed 2021-03-12 | -$32.08M derived: sum of 4 quarters · filed 2021-03-12 | ||||
| 2018-12-31 | -$78.89M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | -$78.89M derived: sum of 2 quarters · filed 2021-03-12 | -$78.89M derived: sum of 3 quarters · filed 2021-03-12 | $11.05M 10-K · filed 2021-03-12 | $89.94M 10-K · filed 2019-03-18 | |||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $0.00 derived: sum of 2 quarters · filed 2019-11-05 | $89.94M 10-Q · filed 2019-11-05 | $144.32M derived: sum of 4 quarters · filed 2020-03-12 | ||||
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $89.94M 10-Q · filed 2019-08-14 | $144.32M derived: sum of 3 quarters · filed 2020-03-12 | $148.82M derived: sum of 4 quarters · filed 2020-03-12 | ||||
| 2018-03-31 | $89.94M 10-Q · filed 2019-05-15 | $144.32M derived: sum of 2 quarters · filed 2020-03-12 | $148.82M derived: sum of 3 quarters · filed 2020-03-12 | |||||
| 2017-12-31 | $54.38M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $58.88M derived: sum of 2 quarters · filed 2020-03-12 | $64.38M 10-K · filed 2020-03-12 | |||||
| 2017-09-30 | $4.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $10.00M 10-Q · filed 2018-11-13 | ||||||
| 2017-06-30 | $5.50M 10-Q · filed 2018-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |